Company news

Monte Rosa Therapeutics, Inc. news in 2021

Monte Rosa Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer

December 1, 2021

Monte Rosa Therapeutics Announces First Development Candidate and Reports Third Quarter 2021 Financial Results and Business Updates

November 9, 2021

Monte Rosa Therapeutics Presents Preclinical Data at AACR-NCI-EORTC Highlighting Potential of Molecular Glue Degraders for the Treatment of Myc-driven Cancer

October 6, 2021

Monte Rosa Therapeutics to Present Late-breaking Preclinical Data on Targeting GSPT1 for Myc-driven Cancers at AACR-NCI-EORTC Virtual International Conference

September 29, 2021

Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® Indexes

September 9, 2021

Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

August 11, 2021

Monte Rosa Therapeutics Announces Pricing of Initial Public Offering

June 22, 2021

Decks in 2021